Clinical trials: Central Serous Chorioretinopathy
Central Serous Chorioretinopathy
Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy
Central serous chorioretinopathy (CSC) is a self-limiting disease that usually associated with good visual prognosis. In some cases, however, CSC may persist and result in permanent retinal or retinal pigment epithelium (RPE)…
- Trial name
- NCT01971190
- Testing
- Intravitreal Aflibercept injection, Half-fluence photodynamic therapy
- Where
- 6 sites in South Korea
- Volunteers
- 43 people
- Sponsor
- Asan Medical Center
Choroidal Thickness
Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment
The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via…
- Trial name
- NCT01610804
- Where
- Germany
- Volunteers
- 18 people, healthy volunteers welcome
- Sponsor
- University Hospital Regensburg
Central Serous Chorioretinopathy
Mindfulness for Central Serous Chorioretinopathy
The primary goal of this clinical trial is to test whether a mindfulness-based treatment is effective at shortening the duration of, and improving the features of, central serous chorioretinopathy in adults.
- Trial name
- MIND'S EYE (NCT07767058)
- Testing
- Mindfulness
- Where
- 6 sites in United Kingdom
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- King's College Hospital NHS Trust
Central Serous Retinopathy (CSR), Sub-Threshold Laser
Treatment of Recurrent and Multifocal Central Serous Chorioretinopathy
The goal of this clinical trial is to learn if subthreshold micropulse laser is a safe, effective, and painless treatment for multifocal and recurrent central serous chorioretinopathy (CSCR) in adults.
- Trial name
- NCT07889518
- Testing
- 577 nm Subthreshold Micropulse Laser
- Where
- Egypt
- Volunteers
- 40 people
- Sponsor
- Benha University
Central Serous Chorioretinopathy
Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy
The purpose of this study is to evaluate the effectiveness as well as the detrimental influence of half-dose and half-fluence modification of verteporfin photodynamic therapy (PDT) for the treatment of prolonged unresolved…
- Trial name
- NCT01019668
- Testing
- Verteporfin PDT, half-dose, verteporfin PDT, half-fluence
- Where
- Taiwan
- Volunteers
- 24 people
- Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital
Central Serous Chorioretinopathy
Central Serous Chorioretinopathy and Micropulse Laser Treatment
To evaluate choroidal and choriocapillaris changes in patients with central serous chorioretinopathy, undergone sub threshold micropulse laser treatment, following any improvement with conservative therapy with Acetazolamide…
- Trial name
- LEVEO (NCT06346405)
- Testing
- Subthreshold Micropulse Laser Treatment
- Where
- Italy
- Volunteers
- 36 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Central Serous Chorioretinopathy
A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
Central serous chorioretinopathy (CSC) is supposedly the fourth most common non-surgical retinopathy after age-related macular degeneration, diabetic retinopathy and branch retinal vein occlusion.
- Trial name
- NCT02215330
- Testing
- Eplerenone, Maltodextrin
- Where
- Austria
- Volunteers
- 60 people
- Sponsor
- Prim. Prof. Dr. Oliver Findl, MBA
Retinal Disease
Evaluation and Treatment of Patients With Retinal Disease
This study offers evaluation and treatment for patients with certain diseases of the retina (the layer of light-sensitive tissue that lines the inside of the eyeball).
- Trial name
- NCT00005784
- Where
- United States
- Volunteers
- 1,000 people
- Sponsor
- National Eye Institute (NEI)
Central Serous Chorioretinopathy
Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)
The purpose of this study is to evaluate the clinical efficacy of an initial subthreshold retinal micropulselasercoagulation versus a single intravitreal 1.5mg bevacizumab injection in central serous choriretinopathy, as the…
- Trial name
- NCT00802906
- Testing
- subthreshold micropulselaser, bevacizumab
- Where
- Germany
- Volunteers
- 12 people
- Sponsor
- Johann Wolfgang Goethe University Hospital
Age-Related Macular Degeneration, Geographic Atrophy
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
To conduct a precision study to assess the microperimetry function of the Spectral OCT/SLO. The study will assess variability across measurements taken by three different operator-device configuration across clinical sites…
- Conditions
- Age-Related Macular Degeneration, Geographic Atrophy, Diabetic Retinopathy, Macular Edema
- Trial name
- NCT01692938
- Where
- 3 sites in United States
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Optos, PLC
Chronic Central Serous Chorioretinopathy
Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population
The aim of the study is to determine the efficacy and safety of treatment with the drug eplerenone in patients with chronic central serous chorioretinopathy.
- Trial name
- NCT02462499
- Testing
- Inspra (eplerenone)
- Where
- Hungary
- Volunteers
- 28 people
- Sponsor
- Semmelweis University
Chronic Central Serous Chorioretinopathy
Microperimetric Evaluation After Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
A half-dose photodynamic therapy, a relative new treatment, has been widely performed to treat central serous chorioretinopathy.
- Trial name
- NCT01434095
- Testing
- half-dose photodynamic therapy
- Where
- Japan
- Volunteers
- 16 people
- Sponsor
- Surugadai Nihon University Hospital
Central Serous Chorioretinopathy
Central Serous Chorioretinopathy: Etiology, Course and Prognosis
Pathogenesis of central serous chorioretinopathy is not entirely understood yet, therefore further investigations are needed. During this study patients with an acute episode of central serous chorioretinopathy are observed with…
- Trial name
- NCT01378130
- Where
- Austria
- Volunteers
- 50 people
- Sponsor
- Medical University of Vienna
Central Serous Chorioretinopathy
Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC)
The purpose of this study is to determine the safety and efficacy of PDT at 30% verteporfin dose in the treatment of CSC.
- Trial name
- NCT01574430
- Testing
- PDT
- Where
- China
- Volunteers
- 131 people
- Sponsor
- Peking University People's Hospital
Central Serous Chorioretinopathy
Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy
Examine the efficacy of brinzolamide for the treatment of central serous chorioretinopathy
- Trial name
- NCT03542006
- Testing
- Brinzolamide Ophthalmic
- Where
- 2 sites in Argentina, Israel
- Volunteers
- 35 people
- Sponsor
- Tel-Aviv Sourasky Medical Center
Central Serous Chorioretinopathy
Multimodal Imaging in Central Serous Chorioretinopathy
This study aims to assess the contribution of the multimodal imaging, combining a routine examination using Optical Coherence Tomography (OCT) with an imaging procedure using adaptive optics retinal camera.
- Trial name
- IMO (NCT02889185)
- Testing
- RTX1 IMAGIN EYE retinal camera
- Where
- France
- Volunteers
- 3 people
- Sponsor
- Centre Hospitalier Universitaire de Besancon
Central Serous Chorioretinopathy, Tomography, Optical Coherence
Effects of OCTA-guided PDT in Acute CSC
OCTA-guided PDT is as safe and effective as ICGA-guided PDT in the treatment of acute central serous chorioretinopathy. Or OCTA-guided PDT is more effective than ICGA-guided PDT in the treatment of acute central serous…
- Trial name
- NCT03497000
- Testing
- OCTA-guided Photodynamic therapy, ICGA-guided Photodynamic therapy
- Where
- China
- Volunteers
- 23 people
- Sponsor
- Peking University People's Hospital
Central Serous Chorioretinopathy
The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
To find the safe effective lowest light dose for photodynamic therapy (PDT). in the treatment of central serous chorioretinopathy.
- Trial name
- NCT01630863
- Testing
- Photodynamic therapy
- Where
- South Korea
- Volunteers
- 45 people
- Sponsor
- Yeungnam University College of Medicine
Central Serous Chorioretinopathy
Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy
This study is a comparison of multifocal electroretinogram assessment between the laser treatment group and the photodynamic therapy group in chronic central serous chorioretinopathy.
- Trial name
- NCT00803517
- Where
- South Korea
- Volunteers
- 24 people
- Sponsor
- Samsung Medical Center
Chorioretinopathy, Central Serous
Crocin Supplementation in CSCR
Preclinical and clinical evidence support the protective effect of crocin on different pathologic pathways involved in central serous chorioretinopathy (CSCR).
- Trial name
- NCT04936490
- Testing
- Crocin
- Where
- Iran
- Volunteers
- 40 people
- Sponsor
- Shiraz University of Medical Sciences